Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP125895.RAVgqE9cHcauMa1RnTB6W_75OMB2y1wxMsnFOwI9qAwaY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP125895.RAVgqE9cHcauMa1RnTB6W_75OMB2y1wxMsnFOwI9qAwaY130_assertion type Assertion NP125895.RAVgqE9cHcauMa1RnTB6W_75OMB2y1wxMsnFOwI9qAwaY130_head.
- NP125895.RAVgqE9cHcauMa1RnTB6W_75OMB2y1wxMsnFOwI9qAwaY130_assertion description "[study showed that ovarian cancer cell lines expressiing cytoplasmic maspin are more sensitive to cisplatin and that cytoplasmic and nuclear maspin expressing ovarian carcinoma patients have longer survival rates ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP125895.RAVgqE9cHcauMa1RnTB6W_75OMB2y1wxMsnFOwI9qAwaY130_provenance.
- NP125895.RAVgqE9cHcauMa1RnTB6W_75OMB2y1wxMsnFOwI9qAwaY130_assertion evidence source_evidence_literature NP125895.RAVgqE9cHcauMa1RnTB6W_75OMB2y1wxMsnFOwI9qAwaY130_provenance.
- NP125895.RAVgqE9cHcauMa1RnTB6W_75OMB2y1wxMsnFOwI9qAwaY130_assertion SIO_000772 16633061 NP125895.RAVgqE9cHcauMa1RnTB6W_75OMB2y1wxMsnFOwI9qAwaY130_provenance.
- NP125895.RAVgqE9cHcauMa1RnTB6W_75OMB2y1wxMsnFOwI9qAwaY130_assertion wasDerivedFrom lhgdn-20090331 NP125895.RAVgqE9cHcauMa1RnTB6W_75OMB2y1wxMsnFOwI9qAwaY130_provenance.
- NP125895.RAVgqE9cHcauMa1RnTB6W_75OMB2y1wxMsnFOwI9qAwaY130_assertion wasGeneratedBy ECO_0000203 NP125895.RAVgqE9cHcauMa1RnTB6W_75OMB2y1wxMsnFOwI9qAwaY130_provenance.